Volume 14, Issue 5, May 2012

Editorial

More on the immune privilege of glioblastoma

Michael Weller

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 527–528, https://doi.org/10.1093/neuonc/nos110

• Extract
• View article

Review

Treatment-related myelodysplasia in patients with primary brain tumors

Joachim M. Baehring and Peter W. Marks

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 529–540, https://doi.org/10.1093/neuonc/nos068

• Abstract
• View article

Case study

Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system

Giselle Sarganas and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 541–546, https://doi.org/10.1093/neuonc/nos056

• Abstract
• View article

Basic and Translational Investigation

Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid

Amanda M. Saratsis and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 547–560, https://doi.org/10.1093/neuonc/nos067

• Abstract
• View article
• Supplementary data

Basic and Translational Investigations

Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo

Harpreet Kaur and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 561–573, https://doi.org/10.1093/neuonc/nos066

• Abstract
• View article

Basic and Translational Investigation

Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma

Xiumei Zhao and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 574–583, https://doi.org/10.1093/neuonc/nos061

• Abstract
• View article
• Supplementary data

Basic and Translational Investigations

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

Courtney A. Crane and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 584–595, https://doi.org/10.1093/neuonc/nos014

• Abstract
• View article

The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma

Immacolata Andolfo and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 596–612, https://doi.org/10.1093/neuonc/nos002

• Abstract
• View article
• Supplementary data

Basic and Translational Investigation

Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

Elana S. Tykocinski and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 613–623, https://doi.org/10.1093/neuonc/nos073

• Abstract
• View article
• Supplementary data

CLINICAL INVESTIGATIONS

Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation

Tony W. Wilson and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 624–630, https://doi.org/10.1093/neuonc/nos064

• Abstract
• View article

The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis

Julio C. Furlan and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 631–640, https://doi.org/10.1093/neuonc/nos062

• Abstract
• View article

Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion

Matthew Crocker and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 641–648, https://doi.org/10.1093/neuonc/nos063

• Abstract
• View article

FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan

Cécile Colavolpe and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 649–657, https://doi.org/10.1093/neuonc/nos012

• Abstract
• View article

Impaired survival and long-term neurological problems in benign meningioma

Hanna van Alkemade and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 658–666, https://doi.org/10.1093/neuonc/nos013

• Abstract
• View article
• Supplementary data

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

Jaime Gállego Pérez-Larraya and others

Neuro-Oncology, Volume 14, Issue 5, May 2012, Pages 667–673, https://doi.org/10.1093/neuonc/nos070

• Abstract
• View article

News and Announcements

Society news

Neuro-Oncology, Volume 14, Issue 5, May 2012, Page 674, https://doi.org/10.1093/neuonc/nos111

• Extract
• View article

Cover/Standing Material

Contents Page

Neuro-Oncology, Volume 14, Issue 5, May 2012, Page NP, https://doi.org/10.1093/neuonc/nos020

• View article

Cover Page

Neuro-Oncology, Volume 14, Issue 5, May 2012, Page NP, https://doi.org/10.1093/neuonc/nos030

• View article

Editorial Board

Neuro-Oncology, Volume 14, Issue 5, May 2012, Page NP, https://doi.org/10.1093/neuonc/nos040

• View article

Subscription Page

Neuro-Oncology, Volume 14, Issue 5, May 2012, Page NP, https://doi.org/10.1093/neuonc/nos050

• View article